Media 2021


Placental cell therapy could deliver new treatment options for liver disease
Medical Express

Why Invion’s progress towards TNBC treatment can be a game changer
Kalkine Media

3D-bioprinted urogynaecological repair treatment
Hospital and healthcare

Insights into Invion’s progress in PhotosoftTM technology for cancer treatment as it gears up for an exciting 2022
Kalkine media

Neural stem cells may hold key to combatting newborn brain injury
News Binding

Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research
Biopharma Reporter
Street Insider
Daily Herald Chicago


New hope in lung cancer war
Herald Sun
Hobart Mercury
Weekend Gold Coast Bulletin
Medical Xpress
News Binding

How the resented AstraZeneca vaccine could save Australia
Daily Mail

Neural stem cells may hold key to combatting newborn brain injury
Today UK News
California News Times

Melbourne scientists have found a way to lessen the side effects of covid-19 vaccines
Radio | 3AW
Radio | 5AA
The Australian

Noxopharm (ASX:NOX) signs licensing agreement with Hudson Institute for RNA technology
The Market Herald
Proactive Investors

New hope for sick newborns
TV | 9 News
TV | 7 News
Radio | 4BC
Herald Sun
Daily Telegraph
Adelaide Advertiser
Courier Mail

Flicking the inflammation off-switch
UK Today News
Florida News Times
Medical Express
Pledge Times


Study shows Invion’s INV043 could regress triple negative breast cancer tumours
Small caps

Invion (ASX:IVX) sees complete regression of tumours in breast cancer trial
The Market Herald

Hudson CEO appointed to NHMRC Council
Hospital Healthcare

Rocks for ROC | a rare ovarian cancer
Radio | ABC Illawarra

Invion has productive quarter following $4.5m capital raise for next-gen photodynamic therapy to treat billion-dollar diseases
Small caps

Noxopharm well-funded to advance “rapidly expanding” clinical program
Proactive Investors

Invion, Dimerix, Orthocell: Promising ASX stocks to watch amid biotech boom
Kalkine Media

Hearts in the right place
CEO Sydney


Renowned Scientists Added To Scientific Advisory Group
Premier of VIC

Hearts in the Right Place: Thian Chew
CEO Magazine

How Do Bats Resist COVID? Insights Could Lead to New Treatments for Humans
Herald Sun
California New Times
USA Newsguru

A GP guide to primary aldosteronism
Australian Doctor Group

Research team lead by Dr Jim Vadolas develops viral gene therapy to treat beta thalassaemia
Neos Kosmos

Invion advances ‘exciting’ photodynamic therapy to treat a range of cancers
Small Caps

Global female scholars award opens for 2022

Can Invion’s promising technology do more than just treat cancer patients?
Kalkline Media

Viruses and the COVID-19 pandemic
Radio | 2NUR


Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19
Street Insider
Galv News
Yahoo Finance

Coffee sellers a sign of pandemic desperation | Covid-19 research
The Australian

Breathing support improves lung function in near-term newborns
Today UK News

Invion Group to expand its promising photodynamic therapy technology into new markets
Small Caps

Noxopharm’s Veyonda® may offer other therapeutic opportunities in chronic inflammatory and autoimmune diseases
Proactive Investors
Yahoo Finance


Geelong MPs questioned on whether they will donate their minimum pay rise to charity
Herald Sun
Geelong Advertiser

Australian biotech submits for approval of world first microbial therapy
News for Business
Pharmacy ITK


Maria Alexiadis OAM: Part-time scientist, part-time Kumite sensei
Greek Herald

New drugs may kill and limit reproduction of bowel cancer cells
TV | 9 News
Radio | 2GB

Photodynamic therapy to reduce tumours
The Pulse


Moderna ‘toxic’ vaccine claim a potent dose of misinformation

Monash team co-develop lung disease drug
Herald Sun
Geelong Advertiser
Adelaide Advertiser

For International HR day, we’re celebrating HR initiatives that help businesses thrive
HRM – Australian HR Institute News

What 2,000-year-old poo says about our gut bugs

Breakthrough discovery for women suffering after traumatic childbirths
Radio | ABC, 5AA
Herald Sun
Courier Mail

Developing early detection test for Ovarian cancer

Protecting premature babies | discussing an often fatal disease called necrotising enterocolitis (NEC)
ABC Babytalk podcast


Noxopharm’s interim trial data indicates Veyonda® potentially prevents cytokine storm in patients with moderately severe COVID-19 


Australian scientists new world-first sperm discovery
TV | National Nine News
Radio | ABC Newcastle

Tackling Ovarian Cancer
Australian Jewish News

Victorian Women Leading COVID-19 Research Charge
Premier of Victoria

Walk For a Worthy Cause
Crandbourne News


Ovarian Cancer: Hope on the Horizon
Tonic magazine

A head start on migraine treatment
The West Australian


Building A Case To Beat The World’s Deadliest Diseases
Premier of Victoria

Hon Jaala Pulford visits Hudson Institute
Mirage News

Noxopharm says study advancing after clinical review